• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型酸缓冲生物粘附性阴道制剂(ACIDFORM)的特性。

Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM).

作者信息

Garg S, Anderson R A, Chany C J, Waller D P, Diao X H, Vermani K, Zaneveld L J

机构信息

Section of Ob/Gyn Research, Rush University, Rush Presbyterian St. Luke's Medical Center, Chicago, IL, USA.

出版信息

Contraception. 2001 Jul;64(1):67-75. doi: 10.1016/s0010-7824(01)00217-7.

DOI:10.1016/s0010-7824(01)00217-7
PMID:11535216
Abstract

Vaginal prophylactic methodology may prevent heterosexual transmission of the HIV and other sexually transmitted disease-causing organisms as well as unplanned pregnancies. A new delivery system (ACIDFORM) was designed with acid-buffering, bioadhesive, and viscosity-retaining properties to (1) maintain the acidic vaginal milieu (the low pH inactivates many pathogens and spermatozoa), (2) form a protective layer over the vaginal/cervical epithelium (minimizing contact with pathogenic organisms), and (3) provide long-term vaginal retention. A Phase I clinical study with ACIDFORM provided initial information about its safety and showed the formation of a layer over the vaginal/cervical epithelium [1; Amaral et al., Contraception 1999;60:361-6]. To study the properties of the gel (without active ingredient) in more detail, ACIDFORM's acid-buffering, bioadhesive, viscosity-retaining, and spermicidal properties were compared in vitro to marketed formulations, and its long-term stability was assessed. ACIDFORM, either when titrated with NaOH or when mixed directly with semen, is highly acid buffering and much more effective than Aci-Jel, a commercial acid-buffering vaginal product. ACIDFORM adheres well to two model membranes (excised sheep vagina and cellophane) and is more bioadhesive than Conceptrol, Advantage S, Replens, Aci-Jel, and K-Y jelly. On dilution, ACIDFORM also retains its viscosity better than these marketed products. ACIDFORM is spermicidal and is stable for at least 2 years. These results suggest that ACIDFORM has advantages over presently marketed vaginal delivery systems. The gel may either be useful by itself as an antimicrobial contraceptive product or as a formulation vehicle for an active ingredient with antimicrobial and/or contraceptive properties.

摘要

阴道预防方法可以预防艾滋病毒及其他性传播致病微生物的异性传播,以及意外怀孕。一种新型给药系统(ACIDFORM)被设计成具有酸缓冲、生物粘附和粘度保持特性,以(1)维持阴道酸性环境(低pH值可使许多病原体和精子失活),(2)在阴道/宫颈上皮上形成一层保护层(使与致病生物的接触最小化),以及(3)实现长期阴道滞留。一项关于ACIDFORM的I期临床研究提供了其安全性的初步信息,并显示在阴道/宫颈上皮上形成了一层[1;阿马拉尔等人,《避孕》1999年;60:361 - 6]。为了更详细地研究该凝胶(不含活性成分)的特性,在体外将ACIDFORM的酸缓冲、生物粘附、粘度保持和杀精特性与市售制剂进行了比较,并评估了其长期稳定性。ACIDFORM在用氢氧化钠滴定或直接与精液混合时,具有高度的酸缓冲能力,比市售的酸缓冲阴道产品Aci - Jel更有效。ACIDFORM能很好地粘附于两种模型膜(切除的羊阴道和玻璃纸),并且比Conceptrol、Advantage S、Replens、Aci - Jel和K - Y胶冻具有更强的生物粘附性。稀释时,ACIDFORM的粘度也比这些市售产品保持得更好。ACIDFORM具有杀精作用,并且至少稳定2年。这些结果表明,ACIDFORM比目前市售的阴道给药系统具有优势。该凝胶本身可作为一种抗菌避孕产品,也可作为具有抗菌和/或避孕特性的活性成分的制剂载体。

相似文献

1
Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM).一种新型酸缓冲生物粘附性阴道制剂(ACIDFORM)的特性。
Contraception. 2001 Jul;64(1):67-75. doi: 10.1016/s0010-7824(01)00217-7.
2
Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.阴道对一种具有酸缓冲作用的生物粘附凝胶——酸福尔姆耐受性的研究。
Contraception. 1999 Dec;60(6):361-6. doi: 10.1016/s0010-7824(99)00102-x.
3
ACIDFORM: a review of the evidence.酸形式:证据综述
Contraception. 2014 Jul;90(1):11-8. doi: 10.1016/j.contraception.2014.01.015. Epub 2014 Jan 28.
4
Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.使用生物黏附性、酸缓冲、杀微生物避孕凝胶(ACIDFORM)和2%壬苯醇醚-9产品后的阴道安全性。
Contraception. 2006 May;73(5):542-7. doi: 10.1016/j.contraception.2005.12.006. Epub 2006 Feb 17.
5
Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.每日两次使用酸(form)阴道凝胶的 I 期随机安全性研究:候选抗菌避孕药。
PLoS One. 2012;7(10):e46901. doi: 10.1371/journal.pone.0046901. Epub 2012 Oct 8.
6
An overview of properties of Amphora (Acidform) contraceptive vaginal gel.安普乐(酸式)避孕阴道凝胶性能概述。
Expert Opin Drug Saf. 2018 Sep;17(9):935-943. doi: 10.1080/14740338.2018.1515197. Epub 2018 Sep 3.
7
Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents.一种用于避孕和抗菌药物的新型长效阴道给药系统(LASRS)的特性。
J Androl. 2001 May-Jun;22(3):481-90.
8
Clinical development of microbicides for the prevention of HIV infection.用于预防艾滋病毒感染的杀微生物剂的临床开发。
Curr Pharm Des. 2004;10(3):315-36. doi: 10.2174/1381612043386374.
9
Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections.用于混合性阴道感染的酸缓冲生物粘附阴道片的研制与评价
AAPS PharmSciTech. 2007 Dec 14;8(4):E109. doi: 10.1208/pt0804109.
10
Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.使用生物粘附性酸缓冲凝胶(ACIDFORM)和2%壬苯醇醚-9产品后的性交后试验。
Contraception. 2004 Dec;70(6):492-7. doi: 10.1016/j.contraception.2004.06.007.

引用本文的文献

1
Non-hormonal Contraception: Current and Emerging Targets.非激素避孕:当前及新出现的靶点
Adv Exp Med Biol. 2025;1469:245-272. doi: 10.1007/978-3-031-82990-1_11.
2
Imiquimod-Loaded Nanosystem for Treatment Human Papillomavirus-Induced Lesions.用于治疗人乳头瘤病毒诱导病变的咪喹莫特纳米系统。
Pharmaceutics. 2024 Jun 27;16(7):864. doi: 10.3390/pharmaceutics16070864.
3
Mechanisms of action of currently available woman-controlled, vaginally administered, non-hormonal contraceptive products.目前可用的女性控制的、经阴道给药的非激素避孕产品的作用机制。
Ther Adv Reprod Health. 2022 Jul 7;16:26334941221107120. doi: 10.1177/26334941221107120. eCollection 2022 Jan-Dec.
4
New Contraception Update - Annovera, Phexxi, Slynd, and Twirla.新型避孕方法更新——安诺薇拉、菲克西、斯林德和特维拉。
Curr Obstet Gynecol Rep. 2022 Mar;11(1):21-27. doi: 10.1007/s13669-021-00321-4. Epub 2022 Jan 6.
5
A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial.一种新型阴道pH调节剂:3期AMPOWER避孕临床试验结果
Contracept X. 2020 Jul 1;2:100031. doi: 10.1016/j.conx.2020.100031. eCollection 2020.
6
Characterization of commercially available vaginal lubricants: a safety perspective.商业化阴道润滑剂的特性:安全性视角。
Pharmaceutics. 2014 Sep 22;6(3):530-42. doi: 10.3390/pharmaceutics6030530.
7
Poly(ethylene glycol) (PEG)-lactic acid nanocarrier-based degradable hydrogels for restoring the vaginal microenvironment.基于聚乙二醇(PEG)-乳酸纳米载体的可降解水凝胶用于恢复阴道微环境。
J Control Release. 2014 Nov 28;194:301-9. doi: 10.1016/j.jconrel.2014.08.031. Epub 2014 Sep 16.
8
Formulation development and evaluation of innovative two-polymer (SR-2P) bioadhesive vaginal gel.新型双聚合物(SR-2P)生物粘附性阴道凝胶的制剂研发与评价
AAPS PharmSciTech. 2014 Aug;15(4):928-38. doi: 10.1208/s12249-014-0124-9. Epub 2014 Apr 30.
9
Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.每日两次使用酸(form)阴道凝胶的 I 期随机安全性研究:候选抗菌避孕药。
PLoS One. 2012;7(10):e46901. doi: 10.1371/journal.pone.0046901. Epub 2012 Oct 8.
10
Noninvasive routes of proteins and peptides drug delivery.蛋白质和肽类药物的非侵入性给药途径。
Indian J Pharm Sci. 2011 Jul;73(4):367-75. doi: 10.4103/0250-474X.95608.